Dr. Oliver Sartor Does It Again

It would appear that a new treatment that is effective in heavily pre-treated patients may be on the near-term horizon.  Dr. Sartor is the lead author of a New England Journal of Medicine (NEJM) article published June 23, 2021 that demonstrates that PSMA-617 Lu-177 prolongs survival in patients with metastatic prostate cancer.  These patients had undergone multiple…

Read More